Article Versions Notes

Ravon F, Berns E, Lambert I, Rens C, Adnet P-Y, Kiass M, Megalizzi V, Delporte C, Baulard A, Mathys V, et al. Assessment of Innovative Dry Powders for Inhalation of a Synergistic Combination Against Mycobacterium tuberculosis in Infected Macrophages and Mice. Pharmaceutics. 2025; 17(6):705. https://doi.org/10.3390/pharmaceutics17060705

Ravon, Faustine, Emilie Berns, Isaline Lambert, Céline Rens, Pierre-Yves Adnet, Mehdi Kiass, Véronique Megalizzi, Cédric Delporte, Alain Baulard, Vanessa Mathys, and et al. 2025. "Assessment of Innovative Dry Powders for Inhalation of a Synergistic Combination Against Mycobacterium tuberculosis in Infected Macrophages and Mice" Pharmaceutics 17, no. 6: 705. https://doi.org/10.3390/pharmaceutics17060705

Ravon, F., Berns, E., Lambert, I., Rens, C., Adnet, P.-Y., Kiass, M., Megalizzi, V., Delporte, C., Baulard, A., Mathys, V., Boarbi, S., Wauthoz, N., & Fontaine, V. (2025). Assessment of Innovative Dry Powders for Inhalation of a Synergistic Combination Against Mycobacterium tuberculosis in Infected Macrophages and Mice. Pharmaceutics, 17(6), 705. https://doi.org/10.3390/pharmaceutics17060705